Loading…
Reported covered position: Senior Advisor - House Republican Conference 2014-2105; Policy Advisor/Professional Staff Member - Rep. Lee Terry/Energy & Commerce Committee; 2012-2014; Legislative Correspondent/Legislative Aide - Sen. Lamar Alexander - 2010-2012
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 1: One Big Beautiful Bill Act; provisions related to permanent Research and Development (R&D) expensing
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 1: One Big Beautiful Bill Act; provisions related to National Institutes of Health and Medicare reimbursement
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ILLUMINA, INC. via ILLUMINA, INC.
2025 · third_quarter · Q3
H.R. 1: One Big Beautiful Bill Act; provisions related to National Institutes of Health and Medicare reimbursement
H.R. 1: One Big Beautiful Bill Act; provisions related to permanent Research and Development (R&D) expensing
Source: Senate LDA
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 1: One Big Beautiful Bill Act; provisions related to permanent Research and Development (R&D) expensing
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R.1968: Full-Year Continuing Appropriations and Extensions Act, 2025; all provisions
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R.1968: Full-Year Continuing Appropriations and Extensions Act, 2025; all provisions
H.R. 2369: VALID Act of 2023; provisions related to the the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests General discussions related to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization General discussions related to Cures 2.0
H.R. 2369: VALID Act of 2023; provisions related to the the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests General discussions related to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
H.R. 2369: VALID Act of 2023; provisions related to the the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests General discussions related to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 2369: VALID Act of 2023; provisions related to the the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests General discussions related to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization General discussions related to Cures 2.0
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
General Discussions related to the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests General Discussions related to Medicaid coverage of Whole Genome Sequencing (WGS) H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 2369: VALID Act of 2023; provisions related to the the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests General discussions related to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 2369: VALID Act of 2023; provisions related to the the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests General discussions related to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
National Defense Authorization Act for Fiscal Year 2024
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
P.L. 118-31 (H.R. 2670): National Defense Authorization Act for Fiscal Year 2024; provisions related to national security and trade
General Discussions related to the Food and Drug Administration's regulation of diagnostics and lab developed test General Discussion related to Medicares payment system for clinical diagnostic laboratory services General discussions related to Multi-Cancer Early Detection technology HR 7085: BIOSECURE Act; all provisions General Discussion related to funding for National Institutes of Health General Discussion related to funding for Centers for Disease Control and Prevention General Discussion related to funding for biosurveillance General Discussions related to the implementation of P.L. 117-167 (HR 4346): Chips and Science Act
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 8070: Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; provisions related to genomics issues pertaining to national security
H.R. 8333: BIOSECURE Act; provisions related to genomics issues pertaining to national security
H.R. 8333: BIOSECURE Act; provisions related to genomics issues pertaining to national security
H.R. 8333: BIOSECURE Act; provisions related to genomics issues pertaining to national security
H.R. 8333: BIOSECURE Act; provisions related to technical issues pertaining to genomics regulation
Continuing Appropriations and Extensions Act, 2025
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 9747: Continuing Appropriations and Extensions Act, 2025; provisions related to government funding
Continuing Appropriations and Extensions Act, 2025
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 9747: Continuing Appropriations and Extensions Act, 2025; provisions related to government funding
Continuing Appropriations and Extensions Act, 2025
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 9747: Continuing Appropriations and Extensions Act, 2025; provisions related to government funding
General Discussions related to the Food and Drug Administration's regulation of diagnostics and lab developed test General Discussion related to Medicares payment system for clinical diagnostic laboratory services General discussions related to Multi-Cancer Early Detection technology HR 7085: BIOSECURE Act; all provisions General Discussion related to funding for National Institutes of Health General Discussion related to funding for Centers for Disease Control and Prevention General Discussion related to funding for biosurveillance General Discussions related to the implementation of P.L. 117-167 (HR 4346): Chips and Science Act
National Defense Authorization Act for Fiscal Year 2024
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 2670: National Defense Authorization Act for Fiscal Year 2024; provisions related to national security and trade
National Defense Authorization Act for Fiscal Year 2024
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 2670: National Defense Authorization Act for Fiscal Year 2024; provisions related to national security and trade
National Defense Authorization Act for Fiscal Year 2024
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 2670: National Defense Authorization Act for Fiscal Year 2024; provisions related to national security and trade
H.R. 4420: Preparedness and Response Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness H.R. 4421: Preparing for All Hazards and Pathogens Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness Public Law No: 117-328 (H.R. 2617-117th Congress): Consolidated Appropriations Act, 2023; General Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, Centers for Disease Control and Prevention surveillance funding and National Institutes of Health funding General Discussions related to the Food and Drug Administration's regulation of diagnostics and lab developed test General Discussion related to Medicares payment system for clinical diagnostic laboratory services General Discussions related to the Cancer Moonshot Initiative General Discussions related to genomic surveillance and pandemic preparedness General Discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
H.R. 4420: Preparedness and Response Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness H.R. 4421: Preparing for All Hazards and Pathogens Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness Public Law No: 117-328 (H.R. 2617-117th Congress): Consolidated Appropriations Act, 2023; General Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, Centers for Disease Control and Prevention surveillance funding and National Institutes of Health funding General Discussions related to the Food and Drug Administration's regulation of diagnostics General Discussion related to Medicares payment system for clinical diagnostic laboratory services General Discussions related to the Cancer Moonshot Initiative General Discussions related to genomic surveillance and pandemic preparedness General Discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
H.R. 4420: To reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Centers for Disease Control and Protection, and for other purposes.; provisions related to pandemic surveillance and national pandemic preparedness H.R. 4421: To reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes.; provisions related to pandemic surveillance and national pandemic preparedness Public Law No: 117-328 (H.R. 2617-117th Congress): Consolidated Appropriations Act, 2023; General Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, Centers for Disease Control and Prevention surveillance funding and National Institutes of Health funding General Discussions related to the Food and Drug Administration's regulation of diagnostics General Discussion related to Medicares payment system for clinical diagnostic laboratory services General Discussions related to the Cancer Moonshot Initiative General Discussions related to genomic surveillance and pandemic preparedness General Discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
Preparing for All Hazards and Pathogens Reauthorization Act
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 4420: To reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Centers for Disease Control and Protection, and for other purposes.; provisions related to pandemic surveillance and national pandemic preparedness H.R. 4421: To reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes.; provisions related to pandemic surveillance and national pandemic preparedness Public Law No: 117-328 (H.R. 2617-117th Congress): Consolidated Appropriations Act, 2023; General Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, Centers for Disease Control and Prevention surveillance funding and National Institutes of Health funding General Discussions related to the Food and Drug Administration's regulation of diagnostics General Discussion related to Medicares payment system for clinical diagnostic laboratory services General Discussions related to the Cancer Moonshot Initiative General Discussions related to genomic surveillance and pandemic preparedness General Discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
Preparing for All Hazards and Pathogens Reauthorization Act
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 4420: Preparedness and Response Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness H.R. 4421: Preparing for All Hazards and Pathogens Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness Public Law No: 117-328 (H.R. 2617-117th Congress): Consolidated Appropriations Act, 2023; General Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, Centers for Disease Control and Prevention surveillance funding and National Institutes of Health funding General Discussions related to the Food and Drug Administration's regulation of diagnostics General Discussion related to Medicares payment system for clinical diagnostic laboratory services General Discussions related to the Cancer Moonshot Initiative General Discussions related to genomic surveillance and pandemic preparedness General Discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
Preparing for All Hazards and Pathogens Reauthorization Act
Client: ILLUMINA, INC. · Firm: ILLUMINA, INC.
H.R. 4420: Preparedness and Response Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness H.R. 4421: Preparing for All Hazards and Pathogens Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness Public Law No: 117-328 (H.R. 2617-117th Congress): Consolidated Appropriations Act, 2023; General Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, Centers for Disease Control and Prevention surveillance funding and National Institutes of Health funding General Discussions related to the Food and Drug Administration's regulation of diagnostics and lab developed test General Discussion related to Medicares payment system for clinical diagnostic laboratory services General Discussions related to the Cancer Moonshot Initiative General Discussions related to genomic surveillance and pandemic preparedness General Discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
H.R. 4420: Preparedness and Response Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness H.R. 4421: Preparing for All Hazards and Pathogens Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness Public Law No: 117-328 (H.R. 2617-117th Congress): Consolidated Appropriations Act, 2023; General Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, Centers for Disease Control and Prevention surveillance funding and National Institutes of Health funding General Discussions related to the Food and Drug Administration's regulation of diagnostics and lab developed test General Discussion related to Medicares payment system for clinical diagnostic laboratory services General Discussions related to the Cancer Moonshot Initiative General Discussions related to genomic surveillance and pandemic preparedness General Discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
Public Law No: 117-328 (H.R. 2617-117th Congress): Consolidated Appropriations Act, 2023; General Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, Centers for Disease Control and Prevention surveillance funding and National Institutes of Health funding General Discussions related to the Food and Drug Administration's regulation of diagnostics General Discussion related to Medicares payment system for clinical diagnostic laboratory services General Discussions related to the Cancer Moonshot Initiative General Discussions related to genomic surveillance and pandemic preparedness General Discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
H.R. 4420: Preparedness and Response Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness H.R. 4421: Preparing for All Hazards and Pathogens Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness Public Law No: 117-328 (H.R. 2617-117th Congress): Consolidated Appropriations Act, 2023; General Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, Centers for Disease Control and Prevention surveillance funding and National Institutes of Health funding General Discussions related to the Food and Drug Administration's regulation of diagnostics General Discussion related to Medicares payment system for clinical diagnostic laboratory services General Discussions related to the Cancer Moonshot Initiative General Discussions related to genomic surveillance and pandemic preparedness General Discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
H.R. 4420: To reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Centers for Disease Control and Protection, and for other purposes.; provisions related to pandemic surveillance and national pandemic preparedness H.R. 4421: To reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes.; provisions related to pandemic surveillance and national pandemic preparedness Public Law No: 117-328 (H.R. 2617-117th Congress): Consolidated Appropriations Act, 2023; General Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, Centers for Disease Control and Prevention surveillance funding and National Institutes of Health funding General Discussions related to the Food and Drug Administration's regulation of diagnostics General Discussion related to Medicares payment system for clinical diagnostic laboratory services General Discussions related to the Cancer Moonshot Initiative General Discussions related to genomic surveillance and pandemic preparedness General Discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
Public Law No: 117-167 (H.R. 4346- 177th Congress): Supreme Court Security Funding Act of 2022 (f.k.a: The CHIPS and Science Act of 2022); All provisions General Discussions related to export control and trade policy
General discussions related to tariffs and trade negotiations
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
ILLUMINA, INC. via ILLUMINA, INC.
2025 · second_quarter · Q2
H.R. 1: One Big Beautiful Bill Act; provisions related to permanent Research and Development (R&D) expensing
Discussions related to Artificial Intelligence
Discussions related to permanent Research and Development (R&D) expensing
Discussions related to Tariffs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ILLUMINA, INC. via ILLUMINA, INC.
2025 · first_quarter · 1A
H.R.1968: Full-Year Continuing Appropriations and Extensions Act, 2025; all provisions
Discussions related to National Institutes of Health funding Discussions related to Laboratory Developed Tests (LDTs) regulation
Discussions related to Disease Detection
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ILLUMINA, INC. via ILLUMINA, INC.
2025 · first_quarter · Q1
H.R.1968: Full-Year Continuing Appropriations and Extensions Act, 2025; all provisions
Discussions related to National Institutes of Health funding Discussions related to Laboratory Developed Tests (LDTs) regulation
Discussions related to Disease Detection
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ILLUMINA, INC. via ILLUMINA, INC.
2024 · fourth_quarter · Q4
H.R. 2369: VALID Act of 2023; provisions related to the the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests General discussions related to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization General discussions related to Cures 2.0
H.R. 9747: Continuing Appropriations and Extensions Act, 2025; provisions related to government funding
H.R. 8333: BIOSECURE Act; provisions related to genomics issues pertaining to national security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ILLUMINA, INC. via ILLUMINA, INC.
2024 · third_quarter · 3A
H.R. 8333: BIOSECURE Act; provisions related to genomics issues pertaining to national security
H.R. 2369: VALID Act of 2023; provisions related to the the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests General discussions related to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
H.R. 9747: Continuing Appropriations and Extensions Act, 2025; provisions related to government funding
ILLUMINA, INC. via ILLUMINA, INC.
2024 · third_quarter · Q3
H.R. 9747: Continuing Appropriations and Extensions Act, 2025; provisions related to government funding
H.R. 2369: VALID Act of 2023; provisions related to the the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests General discussions related to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
H.R. 8333: BIOSECURE Act; provisions related to genomics issues pertaining to national security
ILLUMINA, INC. via ILLUMINA, INC.
2024 · second_quarter · Q2
General Discussions related to the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests General Discussions related to Medicaid coverage of Whole Genome Sequencing (WGS) H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests
H.R. 8333: BIOSECURE Act; provisions related to technical issues pertaining to genomics regulation
H.R. 8070: Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; provisions related to genomics issues pertaining to national security
ILLUMINA, INC. via ILLUMINA, INC.
2024 · first_quarter · Q1
General Discussions related to the Food and Drug Administration's regulation of diagnostics and lab developed test General Discussion related to Medicares payment system for clinical diagnostic laboratory services General discussions related to Multi-Cancer Early Detection technology HR 7085: BIOSECURE Act; all provisions General Discussion related to funding for National Institutes of Health General Discussion related to funding for Centers for Disease Control and Prevention General Discussion related to funding for biosurveillance General Discussions related to the implementation of P.L. 117-167 (HR 4346): Chips and Science Act
P.L. 118-31 (H.R. 2670): National Defense Authorization Act for Fiscal Year 2024; provisions related to national security and trade
ILLUMINA, INC. via ILLUMINA, INC.
2023 · fourth_quarter · Q4
H.R. 2670: National Defense Authorization Act for Fiscal Year 2024; provisions related to national security and trade
H.R. 4420: Preparedness and Response Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness H.R. 4421: Preparing for All Hazards and Pathogens Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness Public Law No: 117-328 (H.R. 2617-117th Congress): Consolidated Appropriations Act, 2023; General Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, Centers for Disease Control and Prevention surveillance funding and National Institutes of Health funding General Discussions related to the Food and Drug Administration's regulation of diagnostics and lab developed test General Discussion related to Medicares payment system for clinical diagnostic laboratory services General Discussions related to the Cancer Moonshot Initiative General Discussions related to genomic surveillance and pandemic preparedness General Discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
ILLUMINA, INC. via ILLUMINA, INC.
2023 · third_quarter · Q3
H.R. 4420: Preparedness and Response Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness H.R. 4421: Preparing for All Hazards and Pathogens Reauthorization Act; provisions related to genomic surveillance and pandemic preparedness Public Law No: 117-328 (H.R. 2617-117th Congress): Consolidated Appropriations Act, 2023; General Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, Centers for Disease Control and Prevention surveillance funding and National Institutes of Health funding General Discussions related to the Food and Drug Administration's regulation of diagnostics General Discussion related to Medicares payment system for clinical diagnostic laboratory services General Discussions related to the Cancer Moonshot Initiative General Discussions related to genomic surveillance and pandemic preparedness General Discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
ILLUMINA, INC. via ILLUMINA, INC.
2023 · second_quarter · Q2
H.R. 2670: National Defense Authorization Act for Fiscal Year 2024; provisions related to national security and trade
H.R. 4420: To reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Centers for Disease Control and Protection, and for other purposes.; provisions related to pandemic surveillance and national pandemic preparedness H.R. 4421: To reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes.; provisions related to pandemic surveillance and national pandemic preparedness Public Law No: 117-328 (H.R. 2617-117th Congress): Consolidated Appropriations Act, 2023; General Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, Centers for Disease Control and Prevention surveillance funding and National Institutes of Health funding General Discussions related to the Food and Drug Administration's regulation of diagnostics General Discussion related to Medicares payment system for clinical diagnostic laboratory services General Discussions related to the Cancer Moonshot Initiative General Discussions related to genomic surveillance and pandemic preparedness General Discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
ILLUMINA, INC. via ILLUMINA, INC.
2023 · first_quarter · Q1
Public Law No: 117-328 (H.R. 2617-117th Congress): Consolidated Appropriations Act, 2023; General Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, Centers for Disease Control and Prevention surveillance funding and National Institutes of Health funding General Discussions related to the Food and Drug Administration's regulation of diagnostics General Discussion related to Medicares payment system for clinical diagnostic laboratory services General Discussions related to the Cancer Moonshot Initiative General Discussions related to genomic surveillance and pandemic preparedness General Discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
General Discussions related to competition, access, and regulatory actions regarding Multi-Cancer Early Detection technology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General Discussions related to export control and trade policy General Discussions related to biotechnology and genomics education
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
General Discussions related to export control and trade policy
General Discussions related to competition, access, and regulatory actions regarding Multi-Cancer Early Detection technology
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Science Foundation (NSF), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
General Discussions related to competition, access, and regulatory actions regarding Multi-Cancer Early Detection technology
H.R. 2670: National Defense Authorization Act for Fiscal Year 2024; provisions related to national security and trade
General Discussions related to export control and trade policy
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Science Foundation (NSF), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
General Discussions related to competition, access, and regulatory actions regarding Multi-Cancer Early Detection technology
General Discussions related to export control and trade policy
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Science Foundation (NSF), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Public Law No: 117-167 (H.R. 4346- 177th Congress): Supreme Court Security Funding Act of 2022 (f.k.a: The CHIPS and Science Act of 2022); All provisions General Discussions related to export control and trade policy
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Science Foundation (NSF), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)